Age 0 3 0 3 B-age
> 4 5 4 5 O
/= 5 7 5 7 O
18 8 10 8 10 B-lower_bound
years 11 16 11 16 I-lower_bound

Collected 0 9 17 26 O
tumor 10 15 27 32 B-cancer
tissue 16 22 33 39 O
is 23 25 40 42 O
inadequate 26 36 43 53 O
for 37 40 54 57 O
DNA 41 44 58 61 O
and 45 48 62 65 O
RNA 49 52 66 69 O
analysis 53 61 70 78 O
and/or 62 68 79 85 O
is 69 71 86 88 O
not 72 75 89 92 O
positive 76 84 93 101 O
for 85 88 102 105 O
adenocarcinoma 89 103 106 120 B-cancer
of 104 106 121 123 I-cancer
the 107 110 124 127 I-cancer
prostate 111 119 128 136 I-cancer

Patients 0 8 137 145 O
with 9 13 146 150 O
prior 14 19 151 156 B-treatment
systemic 20 28 157 165 I-treatment
therapy 29 36 166 173 I-treatment
will 37 41 174 178 O
not 42 45 179 182 O
be 46 48 183 185 O
eligible 49 57 186 194 O
for 58 61 195 198 O
the 62 65 199 202 O
study 66 71 203 208 O
, 71 72 208 209 O
i.e. 73 77 210 214 O
radiation 78 87 215 224 B-treatment
or 88 90 225 227 O
chemo 91 96 228 233 B-treatment
or 97 99 234 236 O
immunotherapy 100 113 237 250 B-treatment

Self 0 4 251 255 O
- 4 5 255 256 O
reported 5 13 256 264 O
race 14 18 265 269 O
of 19 21 270 272 O
African 22 29 273 280 B-ethnicity
American 30 38 281 289 I-ethnicity
or 39 41 290 292 O
Caucasian 42 51 293 302 B-ethnicity
American 52 60 303 311 I-ethnicity

Suspected 0 9 312 321 O
malignancy 10 20 322 332 B-cancer
of 21 23 333 335 I-cancer
prostate 24 32 336 344 I-cancer
cancer 33 39 345 351 I-cancer

